Transfer of WTDCsPam3CSK4 attenuated CDDP-injured AKI and inflammation in CDDP-treated WT recipients (WTWTDCsPam3CSK4), as evidenced by notably lower serum levels of urea (Figure 8A, p<0.05), creatinine (Figure 8B, p<0.05) and inflammatory cytokines (IL-12, IL-1β, IL-6, IL-17, IFN-γ, p<0.05, Fig.8E left panel). This evidence concerns the gene IL17A and acute kidney injury.